Fine ART: Ever Evolving Online Adaptive Radiotherapy Technologies and Clinical Innovations

In the field of Adaptive Radiotherapy (ART), there are significant challenges in ensuring patient safety and treatment efficacy with the proper implementation of ART workflows and ART tools, effectively evaluating and implementing current clinical research, navigating the technical advancements and associated challenges, and adopting this new RT paradigm in clinical practice. This educational activity aims to address these issues by equipping healthcare professionals with the latest knowledge about technical and clinical aspects of ART, highlighting recent clinical trials and novel adaptive platform developments from MRgRT, BgRT, Adaptive Proton Therapy, CBCT based workflows, and best clinical practices. It focuses on enhancing patient safety, understanding cutting-edge research, mastering new technologies, and integrating contemporary clinical practices to improve overall treatment efficacy and patient care in the realm of ART.

The activity is also devoted to the basic scientific innovations, translational physics developments, and clinical deployments of adaptive radiotherapy workflows for the improvement of patient treatments and outcomes. The speakers include physicists, physicians, and a dosimetrist from multiple institutions where adaptive radiotherapy techniques have been developed and deployed for clinical treatments, representing both photon and proton therapy and CBCT, MR, and PET imaging systems.

Topics:

  1. Introductory Comments and Overview of the Session
    Indrin Julian Chetty, PhD, MS, FASTRO
  2. Clinical Rationale for On-Line ART and Rationale for Technologies (MRgRT, CTgRT, BgRT, Protons)
    Michael David Chuong, MD
  3. Online Adaptive Proton Therapy: From Foundational Development to First Treatment
    Francesca Albertini, PhD
  4. MRgRT Recent Scientific Developments
    Neelam Tyagi, PhD
  5. CBCT-Based ART: Revolutionizing Radiotherapy with Artificial Intelligence and Advanced X-Ray Imaging
    Olga Dona Lemus, PhD, DABR
  6. Scientific Development and Clinical Deployment of Biology-guided Radiotherapy (BgRT)
    Murat Surucu, PhD
  7. Personnel Requirements: Staffing, Training and Therapy-Specific Elements of ART
    Samantha Dawes, CMD
  8. Current State of the ART & Future Directions of Image-Guided ART
    Lauren E. Henke, MD, MSCI
  9. Q and A
    Dandan Zheng, PhD - Moderator
    Full Panel 
     

This activity is available from April 1, 2025, through 11:59 p.m. Eastern time on March 31, 2027. 

The content was originally presented and recorded at the 2024 ASTRO Annual Meeting.

Target Audience

The activity is designed to meet the interests of radiation oncologists, physicists, nurses, diagnostic radiologists, radiation therapists, radiation dosimetrists and residents.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Understand the most significant opportunities for clinical development of online adaptive platforms.
  • Identify clinical applications and most beneficial patient populations for online adaptive therapies. 
  • Assess their own potential for implementing an adaptive program at their facility. 
Course summary
Available credit: 
  • 2.00 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Enduring material for a maximum of 2.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 2.00 Certificate of Attendance
    This activity was designated for 2.00 AMA PRA Category 1 Credit™.
Course opens: 
04/01/2025
Course expires: 
03/31/2027
Cost:
$149.00
Rating: 
0
  • Brian Winey, PhD, is employed by Harvard Medical School/Massachusetts General Hospital. Dr. Winey receives salary support as the principal investigator of a grant with the NIH. Dr. Winey is a patent holder and receives no royalties or renumeration. Dr. Winey serves as Vice Chair of the ASTRO SEPD Subcommittee. 
  • Indrin Julian Chetty, PhD, MS, FASTRO, is employed by Cedars-Sinai Medical Center. Dr. Chetty is a member of the AAPM Awards and Honors committee and a Board member of the Indian American Society of Medical Physics. 
  • Michael David Chuong, MD, is employed by Miami Cancer Institute, Baptist Health South Florida. Dr. Chuong receives grant/research funding from ViewRay and Novocure. Dr. Chuong is a member of the Board of Directors for the Proton Collaborative Group. 
  • Francesca Albertini, PhD, is employed by Center for Proton Therapy, Paul Scherrer Institute. Dr. Albertini receives grant/research funding from RAPTOR. 
  • Neelam Tyagi, PhD, is employed by Memorial Sloan Kettering Cancer Center. Dr. Tyagi receives honoraria and travel expenses from Elekta and Philips. 
  • Olga Dona Lemus, PhD, DABR, is employed by University of Miami. 
  • Murat Surucu, PhD, is employed by Stanford University. Dr. Surucu receives grant/research funding and honoraria from RefleXion Medical Inc. 
  • Samantha Dawes, CMD, is employed by American Society for Radiation Oncology (ASTRO).
  • Lauren E. Henke, MD, MSCI, is employed by University Hospitals Seidman Cancer Center, Case Western Reserve University. Dr. Henke receives honoraria from ViewRay and Varian Medical Systems/Siemens. Dr. Henke serves on the advisory board of Elekta. 
  • Dandan Zheng, PhD, is employed by University of Rochester. 

The person(s) above served as the developer(s) of this activity. Additionally, the ASTRO Education Committee had control over the content of this activity. All relevant financial relationships have been mitigated.

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Available Credit

  • 2.00 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Enduring material for a maximum of 2.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 2.00 Certificate of Attendance
    This activity was designated for 2.00 AMA PRA Category 1 Credit™.

Price

Cost:
$149.00
Please login or register to take this course.

Course Fees:
ASTRO members must log in to the ASTRO website to view and receive the member rate.

  • Nonmember: $149
  • Member: $99
  • Member-in-Training: $49
  • Student/Graduate Student/PGY-1 Member: $49
  • Postdoctoral Fellow Member: $49

If you are an ASTRO member from a low or lower-middle income country, as identified by the World Bank, you can receive a 50% discount off your corresponding registration for this activity. Please email [email protected] to inquire about the discount.

Policies:
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the activity by the expiration date. 

Participants using ASTRO Academy activities to satisfy the requirement of a Continuing Certification (MOC) program should verify the credit number and type and availability dates of any activity before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased activities that do not align with their MOC requirement.

The activity and its materials will only be available on the ASTRO website until March 31, 2027, regardless of purchase date. At the expiration of the activity, participants will no longer have access to the activity or its materials. ASTRO reserves the right to remove an activity before its expiration date. 

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.